Search clinical trials for: Rusfertide

Total 4 results

Protagonist Therapeutics, Inc.

Completed

PTG-300 in Subjects With Hereditary Hemochromatosis

Hereditary Hemochromatosis

United States, Canada
Protagonist Therapeutics, Inc.

Enrolling by invitation

Study to Evaluate the Long-term Safety of Rusfertide (PTG-300) in Subjects With Polycythemia Vera (THRIVE)

Polycythemia Vera

United States
Protagonist Therapeutics, Inc.

Completed

PTG-300 in Patients With Polycythemia Vera and Elevated Hematocrit (PACIFIC)

Polycythemia Vera

Korea, Republic of, Malaysia
Protagonist Therapeutics, Inc.

Recruiting

A Phase 3 Study of Rusfertide in Patients With Polycythemia Vera (VERIFY)

Polycythemia Vera

United States, Hong Kong, Israel, Canada, Spain, Australia, Austria, Germany, United Kingdom, Hungary, Netherlands, Czechia, Portugal, Italy, Poland, France, Belgium, Chile, Turkey, Mexico

3

Subscribe